Comparison between Proventus Agrocom IPO and Remus Pharmaceuticals IPO.
Proventus Agrocom IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Sundae Capital Advisors Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Ajcon Global Services Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Proventus Agrocom IPO is up to ₹66.06 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹45.29 Cr. The final issue price of Proventus Agrocom IPO is ₹771.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,150.00 per share | |
| Issue Price (Upper) | ₹1,229.00 per share | |
| Issue Price (Final) | ₹771.00 per share | ₹1,229.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 160 shares | 100 shares |
| Fresh Issue Size | 6,26,653 shares | 3,68,500 shares |
| Fresh Issue Size (Amount) | up to ₹48.31 Cr | up to ₹45.29 Cr |
| OFS Issue Size | 2,30,147 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹17.74 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,56,800 shares | 3,68,500 shares |
| Issue Size Total (Amount) | up to ₹66.06 Cr | up to ₹45.29 Cr |
Proventus Agrocom IPO opens on May 24, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Proventus Agrocom IPO and Remus Pharmaceuticals IPO is May 26, 2023, and May 19, 2023, respectively.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | May 16, 2023 | |
| Issue Open | May 24, 2023 | May 17, 2023 |
| Issue Close | May 26, 2023 | May 19, 2023 |
| Basis Of Allotment (Tentative) | May 31, 2023 | May 24, 2023 |
| Initiation of Refunds (Tentative) | Jun 01, 2023 | May 25, 2023 |
| Credit of Share (Tentative) | Jun 02, 2023 | May 26, 2023 |
| Listing date (Tentative) | Jun 05, 2023 | May 29, 2023 |
| Anchor Lockin End date 1 | Jun 23, 2023 | |
| Anchor Lockin End date 2 | Aug 22, 2023 |
Proventus Agrocom IPO P/E ratio is 186.23, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.29 | 92.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.84 | 68.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 186.23 | 21.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹264.27 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.04% | 71.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 0.05% | 69.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.56 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.14 | ₹33.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 3.08% | 52.64% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Proventus Agrocom IPO Retail Individual Investors (RII) are offered 4,28,450 shares while in Remus Pharmaceuticals IPO retail investors are offered 4,28,450 shares. Qualified Institutional Buyers (QIB) are offered in Proventus Agrocom IPO and 73,700 shares in Remus Pharmaceuticals IPO.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 1,10,500 shares | |
| Market Maker Reserveration | 45,120 shares | 19,500 shares |
| QIB | 73,700 shares | |
| NII | 4,28,450 shares | 55,300 shares |
| RII | 4,28,450 shares | 1,29,000 shares |
| Employee | ||
| Others | ||
| Total | 8,56,900 shares | 3,68,500 shares |
Proventus Agrocom IPO subscribed 2.70x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
| Proventus Agrocom IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 10.75x | |
| NII (times) | 4.65x | 229.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.74x | 49.81x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.70x | 57.21x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
